Irina V. Balyasnikova

Author

Also Known As

Balyasnikova I, Balyasnikova, Irina V, Balyasnikova, Irina V., I V Balyasnikova, I. Balyasnikova, I. V. Balyasnikova, I.V. Balyasnikova, IRINA V. BALYASNIKOVA, Irina Balyasnikova, Irina V Balyasnikova

244

Publications

5.6K

Citations

H-Index

107

Concepts

All Affiliations

Northwestern University University of Illinois Chicago University of Chicago Neurological Surgery Northwestern Medicine

About

Irina V. Balyasnikova is an author at Northwestern University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	32	2K
2	Engineering	5	5	653
3	Natural Sciences	4	4	128
4	Health Sciences	2	2	87
5	Social Sciences	1	1	57

Irina V. Balyasnikova

Publications

5.2K

Citations

H-Index

Page 1

	Year	Citations
IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival Derek A. Wainwright, Irina V. Balyasnikova, Alan L. Chang, Clinical Cancer Research	2012	461
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants Giedre Krenciute, Brooke Prinzing, Zhongzhen Yi, Cancer Immunology Research	2017	305
Functional single-cell hybridoma screening using droplet-based microfluidics Bachir El Debs, Ramesh Utharala, Irina V. Balyasnikova, Proceedings of the National Academy of Sciences EngineeringImmunologyBiological TherapyOrgan-on-a-chipBiomedical Engineering	2012	275
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo Paul N. Reynolds, Stuart A. Nicklin, Lioudmila Kaliberova, Nature Biotechnology Transcriptional RegulationTransgene ExpressionGene RegulationSystems BiologyMedicine	2001	225
A Targetable, Injectable Adenoviral Vector for Selective Gene Delivery to Pulmonary Endothelium in Vivo Paul N. Reynolds, Kurt R. Zinn, V D Gavrilyuk, Molecular Therapy	2000	202
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma Peng Zhang, Aida Rashidi, Junfei Zhao, Nature Communications	2023	195
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial Jawad Fares, Atique U. Ahmed, Ilya V. Ulasov, The Lancet Oncology Neuro-oncologyGliomaNeural Stem CellDose-escalation TrialRadiation Oncology	2021	191
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma Peng Zhang, Jason Miska, Catalina Lee-Chang, Proceedings of the National Academy of Sciences NanotherapeuticsEngineeringImmunologyImmunoeditingImmunotherapeutics	2019	156
Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma Yu Cheng, Megan E. Muroski, D. Petit, Journal of Controlled Release MagnetismNeuro-oncologyEngineeringMagnetic ParticlesMagnetic Resonance	2015	151
Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma Atique U. Ahmed, Bart Thaçi, Nikita G. Alexiades, Molecular Therapy	2011	128

Page 1